4.97

4.24% -0.22

Sophia Genetics Sa (SOPH)

Overview News Price History Option Chain Discussions Forecast

Sophia Genetics Sa stock is traded at $4.97, with a volume of 105.29K. It is down -4.24% in the last 24 hours and up +9.47% over the past month. Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Previous Close:

$5.19

Open:

$5.13

24h Volume:

105.29K

Relative Volume:

0.58

Market Cap:

$356.19M

Revenue:

$77.27M

Net Income/Loss:

$-79.00M

P/E Ratio:

-4.25

EPS:

-1.1694

Net Cash Flow:

$-48.46M

1W Performance:

-0.60%

1M Performance:

+9.47%

6M Performance:

+31.48%

1Y Performance:

+59.29%

1-Day Range:

$4.89

$5.25

1-Week Range:

$4.63

$5.35

52-Week Range:

$2.58

$5.70

Sophia Genetics Sa Stock (SOPH) Company Profile

Name

Sophia Genetics Sa

Sector

Healthcare (1113)

Industry

Health Information Services (50)

Phone

Address

Employee

415

Twitter

Next Earnings Date

2025-03-04

Latest SEC Filings

SOPH's Discussions on Twitter

Compare SOPH vs VEEV, TEM, BTSG, HQY, WAY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SOPH Sophia Genetics Sa	4.97	356.19M	77.27M	-79.00M	-48.46M	-1.1694
VEEV Veeva Systems Inc	179.11	29.44B	3.20B	908.91M	1.39B	5.4168
TEM Tempus Ai Inc	48.83	8.73B	1.27B	-245.03M	-245.36M	-1.4071
BTSG Brightspring Health Services Inc	43.31	8.32B	12.91B	104.80M	394.69M	0.8769
HQY Healthequity Inc	82.10	6.94B	1.31B	215.20M	408.32M	2.4627
WAY Waystar Holding Corp	24.03	4.61B	1.10B	112.09M	283.19M	0.6096

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-18-24	Initiated	Craig Hallum	Buy
Aug-07-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-27-24	Initiated	Guggenheim	Buy
Nov-29-23	Initiated	RBC Capital Mkts	Outperform
Jul-05-23	Resumed	JP Morgan	Overweight
Jan-03-23	Initiated	BTIG Research	Buy
Nov-23-22	Initiated	Credit Suisse	Neutral
Oct-15-21	Resumed	Cowen	Outperform
Aug-17-21	Initiated	Cowen	Outperform
Aug-17-21	Initiated	Credit Suisse	Outperform
Aug-17-21	Initiated	JP Morgan	Overweight
Aug-17-21	Initiated	Morgan Stanley	Overweight

View All

Sophia Genetics Sa Stock (SOPH) Latest News

Mar 23, 2026

SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $21,398.22 in Stock - Defense World

Mar 23, 2026

Mar 20, 2026

SOPH SEC FilingsSophia Genetics Sa 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 20, 2026

SOPHiA GENETICS (NASDAQ:SOPH) CEO Jurgi Camblong Sells 4,486 Shares - MarketBeat

Mar 20, 2026

Mar 19, 2026

Form 144 SOPHiA GENETICS SA For: 19 March - Investing.com

Mar 19, 2026

Market Outlook: Is SOPHiA GENETICS SA a momentum stock2026 Earnings Surprises & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Mar 19, 2026

ZHENYU XU sells shares under 10b5-1 plan (SOPH) - Stock Titan

Mar 19, 2026

Restricted Stock Units Sale Notice (SOPH) — 10b5-1 Transactions Listed - Stock Titan

Mar 19, 2026

1,183 RSUs Listed for Sale by SOPH Insider (NASDAQ: SOPH) - Stock Titan

Mar 19, 2026

Proposed sale of 774 Restricted Stock Units (SOPH) reported in Form 144 - Stock Titan

Mar 19, 2026

Morgan Stanley Smith Barney LLC (NASDAQ: SOPH) files Form 144 for 608 RSUs - Stock Titan

Mar 19, 2026

Manuela Valente 10b5-1 sales reported for SOPH (SOPH) - Stock Titan

Mar 19, 2026

[144] SOPHiA GENETICS SA SEC Filing - Stock Titan

Mar 19, 2026

Form 144 SOPHiA GENETICS SA For: 19 March By Investing.com - Investing.com Canada

Mar 19, 2026

Mar 16, 2026

Jurgi Camblong (SOPH) reports multiple 10b5-1 sales across late 2025–2026 - Stock Titan

Mar 16, 2026

Trend Report: Can SOPHiA GENETICS SA continue delivering strong returns2026 Risk Factors & Stock Portfolio Risk Management - baoquankhu1.vn

Mar 16, 2026

Growth Recap: Why is SOPHiA GENETICS SA stock going downTake Profit & Accurate Entry/Exit Alerts - baoquankhu1.vn

Mar 16, 2026

Mar 15, 2026

SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Significant Decrease in Short Interest - MarketBeat

Mar 15, 2026

Mar 09, 2026

[EFFECT] SOPHiA GENETICS SA SEC Filing - Stock Titan

Mar 09, 2026

Mar 08, 2026

Sophia Genetics Earnings Call: Growth Surges, Losses Linger - TipRanks

Mar 08, 2026

Mar 07, 2026

Aug PreEarnings: Can SOPHiA GENETICS SA stock double in the next yearJuly 2025 Momentum & High Yield Equity Trading Tips - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

SOPHiA GENETICS (SOPH) Q4 Loss Deepens And Reinforces Bearish Profitability Concerns - Sahm

Mar 06, 2026

Mar 05, 2026

Will SOPHiA GENETICS SA stock go up in YEARQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn

Mar 05, 2026

SOPHiA GENETICS Q4 Earnings Call Highlights - Defense World

Mar 05, 2026

Mar 04, 2026